Transforming Neurological Healthcare
At LVIS Corporation, we are dedicated to enhancing neurological healthcare through cutting-edge technology. Our team is driven by a passion for innovation and a commitment to solving complex neurological challenges. Together, we can expand the delivery of neurological care to those in need, while we redefine the landscape of neurological diagnosis and treatment, one breakthrough at a time, with our advanced neural information analysis tools.
LVIS: AT A GLANCE
LVIS is a technology company developing products to revolutionize neuro care through rapid and accurate identification of complex neural network patterns.
NeuroMatch® is the LVIS software as a medical device product line which will exponentially increase neurological patient throughput by enabling AI to interpret data in a matter of seconds (digital) rather than hours (analog).
NeuroMatch® data library safely and securely archives patient data with fast accessibility at a fraction of the cost of onsite storage.
LVIS utilizes breakthroughs sourced from its data library to selectively develop, acquire, and joint venture various pharmaceutical and therapeutic candidates which our models forecast to change patient care.
THE LVIS STORY
Commitment to Innovation
Established in 2013 and based in Palo Alto, California, LVIS Corporation is a pioneer in the field of neurotechnology. With exclusive licenses of patents from esteemed institutions like UCLA and Stanford, plus our own robust IP, we provide unparalleled tools to empower physicians. Our commitment to innovation is bolstered by over a decade of research led by our founder, Jin Hyung Lee, an Associate Professor of Neurology, Neurosurgery, and Bioengineering at Stanford University.
LVIS Timeline
History in the Making
2013
- Established LVIS Corporation in Palo Alto, California USA
2014
- Exclusive licensing established with UCLA
2015
- Exclusive licensing established with Stanford University
2022
- Expanded to new LVIS Global Headquarters building in Palo Alto, CA
2023
- First FDA clearance for NeuroMatch in the USA
- First MFDS clearance for NeuroMatch in South Korea
- Established Daegu Office
- First exhibit at AES
2024
-
First exhibit at ACNS
-
Opening of LVIS NeuroMatch Center in Daegu, Korea
-
Launched NeuroMatch in 10 major hospitals in South Korea
-
Inaugural NeuroForum
-
Launched NeuroMatch Access in US
-
Launched NeuroMatch Access, Pro, and Elite in Korea
-
Exhibit at Future Innovation Tech. Expo, FIX 2024
-
Exhibit at AES 2024